Molecular mechanisms for drug interactions with hERG that cause long QT syndrome

Author： Stansfeld Phillip J Sutcliffe Michael J Mitcheson John S

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.2, Iss.1, 2006-02, pp. : 81-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

hERG-related drug toxicity and models for predicting hERG liability and QT prolongation

By Raschi Emanuel Ceccarini Luisa De Ponti Fabrizio Recanatini Maurizio

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1005-1021

Informa Healthcare

Access to resources Recommend Favorite

The Interactions Between hERG Potassium Channel and Blockers

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 330-338

Bentham Science Publishers

Access to resources Recommend Favorite

Tuning hERG Out: Antitarget QSAR Models for Drug Development

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-01 ,pp. : 1399-1415

Bentham Science Publishers

Access to resources Recommend Favorite

The hERG Channel and Risk of Drug-Acquired Cardiac Arrhythmia: An Overview

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-09 ,pp. : 1102-1112

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3514-3532

Bentham Science Publishers

Access to resources Recommend Favorite